Close-up of futuristic concept for integrated circuitry.
Resource

UK Cryptoasset Regulatory Tracker

Latham’s new interactive online resource helps cryptoasset businesses stay up to date with the UK's rapidly evolving regulatory landscape.

Read More
Medium angle digital rendering blurred focus of sports stadium at night.
Game Changer

Latham Advises Apollo Sports Capital on Investment in Wrexham AFC

Read More
Close-up on Ionic columns of a courthouse.
Litigators of the Week Winner

Latham Secures Complete Dismissal of SEC Case Against SolarWinds

Read More
Close-up of woman wearing headphones with sun in background.
Landmark Transaction

Latham Advises Suno in Groundbreaking Partnership With Warner Music Group

Read More
Computer Neural Network Concept Image
Setting a New Standard

Latham Represents Coinbase in Landmark Launch of End-to-End Token Sales Platform

Read More
Close-up of test tubes in a laboratory.
Healthcare Private Equity Exit

Latham Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific

Read More
Wide angle of futuristic data center.
Historic Data Center Deal

Latham Advises Macquarie Asset Management in Largest-Ever Global Data Center Transaction

Read More
A man with a neon joystick in the dark playing video game on a computer.
Historic Take-Private

Latham Advises Silver Lake in US$55 Billion Acquisition of Electronic Arts

Read More
Wide angle of concert stage with spotlights and crowd.
Live Debut

Latham Represents StubHub in US$800 Million IPO

Read More
Arc-shaped copper colored light trails with blue tones
Transformative Transaction

Latham Advises Anglo American on US$70 Billion Merger of Equals with Teck

Read More
3to2 - GettyImages-1491285867_Blue divergent technology curve particle background
Landmark AI Funding Round

Latham Advises General Catalyst and a16z on Mistral AI’s €1.7 Billion Series C Funding Round

Read More
Airport
Landmark Victory

Lufthansa Succeeds in Feeder Flights Dispute Against Condor

Read More
High angle down of coworkers meeting in communal area of a modern office space.
Tech Take-Private

Latham Advises on Financing for Dayforce’s US$12.3 Billion Agreement With Thoma Bravo to Become a Private Company

Read More
“Latham & Watkins’ ability both to spot market opportunities for expanding legal practices and to deploy AI and proprietorial data exemplifies how a law firm can establish a position in the new AI economy.”
Most Innovative Law Firm in North America 2025

Financial Times

23 Consecutive Years on the A-List
Latham consistently ranks among the very top-performing firms across financial and cultural measures.

The American Lawyer A-List 2025

Most Rankings for 11th Consecutive Year
Recognized across a range of transactional, disputes, regulatory, and industry categories, Latham earned 90 Band 1 practice rankings, 96 Band 1 lawyer rankings, and the highest number of lawyers ranked in the guide.

Chambers USA 2025

Law Firm of the Year for Sixth Consecutive Year
Won “Practice Group of the Year” in three categories, while being nominated across six areas in total.

Law360 2024

Advised on more billion-dollar year-end deals than any other law firm in 2024

The American Lawyer and Law.com International

More than 100 #1 rankings across global, regional, and industry M&A and PE league tables in 2024

Bloomberg, LSEG, Mergermarket, Law360

“Latham & Watkins is the absolute go-to firm for anything that is complex and requires fast turnaround times. They are number one.”

Chambers UK 2024

Our Stories

202506-SummerProg-Thumb-750x715-2.png
Spring Challenge 2025
202502-ATX_Open_BGCA-Thumb2-750x715.png

Spring Challenge

Latham’s annual Spring Challenge focuses on overall well-being, camaraderie, and engagement across the globe.

ATX Open Kids Day

Latham co-hosted a youth tennis clinic with Boys & Girls Club of the Austin Area ahead of the 2025 tournament.

What is LathamTech?

In 2024, we partnered with clients across the tech ecosystem to drive tech forward.

Featured Insights

Close-up of green and blue pill capsules in blister pack.
December 12, 2025 Article

The Patent Cliff in the Pharmaceutical Industry

For numerous blockbuster drugs, the underlying patent protection will expire in the coming years. In M&A Review, partners Henning C. Schneider, Christoph Engeler, and Deniz Tschammler discuss strategic M&A and collaborations as a response for big pharma and financial investors (in German).
Read More